Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023

BUY
$2.49 - $11.85 $206 - $983
83 Added 592.86%
97 $0
Q4 2022

Feb 02, 2023

BUY
$10.25 - $22.43 $143 - $314
14 New
14 $0
Q2 2022

Aug 03, 2022

SELL
$9.03 - $21.55 $113,777 - $271,530
-12,600 Closed
0 $0
Q1 2022

Apr 29, 2022

BUY
$15.0 - $22.83 $189,000 - $287,658
12,600 New
12,600 $263,000
Q1 2021

Apr 26, 2021

SELL
$39.04 - $64.6 $1.37 Million - $2.26 Million
-35,000 Closed
0 $0
Q4 2020

Jan 25, 2021

BUY
$42.46 - $56.58 $1.49 Million - $1.98 Million
35,000 New
35,000 $1.62 Million

Others Institutions Holding BTAI

About BioXcel Therapeutics, Inc.


  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $14.3M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.